Lexaria Bioscience - Stock Price History | LEXX

Historical daily share price chart and data for Lexaria Bioscience since 2021 adjusted for splits. The latest closing stock price for Lexaria Bioscience as of September 27, 2021 is 6.85.
  • The all-time high Lexaria Bioscience stock closing price was 8.44 on July 21, 2021.
  • The Lexaria Bioscience 52-week high stock price is 12.50, which is 82.5% above the current share price.
  • The Lexaria Bioscience 52-week low stock price is 3.98, which is 41.9% below the current share price.
  • The average Lexaria Bioscience stock price for the last 52 weeks is 6.07.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Lexaria Bioscience Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.035B $0.000B
Lexaria Bioscience Corp. provides drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. Lexaria Bioscience Corp. is based in Kelowna, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29